Skip to main content

Sustainable Influenza Vaccine Production Capacity Stakeholders' Workshop: Day 2 Videos

January 12, 2010 - Washington, D.C.
Videos Videos: DAY 1 | DAY 2 | DAY 3

Identifying Needs and Assessing Capabilities of Developing Countries

Presentation and discussion session.
  • PATH's Vaccine Development Program: Accelerating Development of Vaccines for Low-Resource Countries by Dr. John Boslego
Essential Needs and Current Gaps: Regulatory Support

Presentations and discussion session.
  • FDA and Influenza Vaccines by Dr.Philip Krause
  • Regulatory Mentoring to Strengthen Capacity: A Case Study of the WHO-Canada-India Initiative by Ms.Catherine Parker
  • Essential Needs and Current Gaps: Regulatory Support by Dr.David Wood
  • Outcomes of the PAHO/WHO Meeting reviewing vaccine regulatory activities for pandemic influenza H1N1 by Dr.Maria de los Angeles Cortes

Essential Needs and Current Gaps: Surveillance and Laboratory Support for Vaccine Development

Presentations and discussion session.
  • Essential Needs and Current Gaps: Surveillance and Laboratory Support for Vaccine Development by Dr. Nancy Cox
  • Laboratory Support for Influenza Vaccine Development - Potency Reagents by Dr. Jerry P. Weir
Short-, Medium- and Long-Term Strategies and Milestones

Presentation:
  • Short-, Medium- and Long-Term Strategies and Milestones in Developing Sustainable Vaccine Production Capacity by Dr. Daniel Miller
Discussion and Final Comments from Day 2